5AM Ventures V sold 200,000 shares (200.0K) of TRDA at $8.80, reducing stake to 2,963,066 shares; stock +50.3% in 30 days.
5AM Ventures V, a 10% owner, sold 200,000 shares (200.0K shares) at $8.80 on 2025-11-14, exiting 6.3% of its pre-transaction holdings of 3,163,066 shares (3.16M shares). The sale occurred after a sharp 30-day run of +50.3%, bringing the stock to $8.82 currently, yet still -59.2% from its 52-week high of $21.59. Entrada is an unprofitable clinical-stage company with net income of $-44,134,000.00 ($-44.1M) in the latest period, though annual revenue growth stands at +63.4%. This sale by a significant institutional holder during a rapid recovery phase, against a backdrop of net losses and substantial distance from year-high valuations, warrants investor attention to the sustainability of the recent momentum and the fund's confidence in the current trajectory.